未登录

S

Stefan Hammerschmidt

johannes gutenberg university of mainz

H指数:30

被引数:3,266

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Peptidyl nitroalkene inhibitors of main protease rationalized by computational and crystallographic investigations as antivirals against SARS-CoV-2

COMMUNICATIONS CHEMISTRY

IF6.2

2024-01-182

OAAI

The effects of allosteric and competitive inhibitors on ZIKV protease conformational dynamics explored through smFRET, nanoDSF, DSF, and 19F NMR

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-10-011

PRE

Next Generation of Fluorometric Protease Assays: 7-Nitrobenz-2-oxa-1,3-diazol-4-yl-amides (NBD-Amides) as Class-Spanning Protease Substrates

CHEMISTRY-A EUROPEAN JOURNAL

IF3.7

2023-07-281

OA

Structure-based lead optimization of peptide-based vinyl methyl ketones as SARS-CoV-2 main protease inhibitors

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2023-02-0116

OAAI

Improving binding entropy by higher ligand symmetry? - A case study with human matriptase

RSC MEDICINAL CHEMISTRY

IF3.6

2023-01-012

OA

Nintedanib plus docetaxel after progression on first-line immunochemotherapy in patients with lung adenocarcinoma: Cohort C of the non-interventional study, VARGADO

肺腺癌患者一线免疫化疗进展后Nintedanib加多西他赛: 非干预性研究的队列C，VARGADO

TRANSLATIONAL LUNG CANCER RESEARCH

IF3.5

2022-10-0115

OAAI

Real-World Efficacy of Nintedanib Plus Docetaxel After Progression on Immune Checkpoint Inhibitors: Results From the Ongoing, Non-interventional VARGADO Study

CLINICAL ONCOLOGY

IF3

2022-07-0114

OAAI

Development of Urea-Bond-Containing Michael Acceptors as Antitrypanosomal Agents Targeting Rhodesain

ACS MEDICINAL CHEMISTRY LETTERS

IF4

2022-06-3012

OAAI

Identification, Characterization, and Synthesis of Natural Parasitic Cysteine Protease Inhibitors: Pentacitidins Are More Potent Falcitidin Analogues

ACS CHEMICAL BIOLOGY

IF3.8

2022-03-092

PRE

Interface with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy

CURRENT MEDICINAL CHEMISTRY

IF3.5

2022-02-0112

PRE

2-Sulfonylpyrimidines as Privileged Warheads for the Development of S. aureus Sortase A Inhibitors

FRONTIERS IN MOLECULAR BIOSCIENCES

IF4

2022-01-0311

OAAI

SAR of novel benzothiazoles targeting an allosteric pocket of DENV and ZIKV NS2B/NS3 proteases

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2021-10-0133

PREAI

Second-line nintedanib plus docetaxel for patients with lung adenocarcinoma after first-line chemo-immunotherapy treatment: Updated efficacy and safety results from VARGADO Cohort C

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Lead Discovery of SARS-CoV-2 Main Protease Inhibitors through Covalent Docking-Based Virtual Screening

JOURNAL OF CHEMICAL INFORMATION AND MODELING

IF5.3

2021-03-3037

PREAI

Deal;Structure-Activity Relationships of Benzamides and Isoindolines Designed as SARS-CoV Protease Inhibitors Effective against SARS-CoV-2

IF3.4

2020-10-1638

OAAI

Efficacy and safety of nintedanib plus docetaxel in lung adenocarcinoma patients (pts) after failure of previous immune checkpoint inhibitor therapy (ICIs): Updated results from the ongoing non-interventional study (NIS) VARGADO (NCT02392455)

ANNALS OF ONCOLOGY

IF65.4

2020-09-013

OAAI

Asymmetric Disulfanylbenzamides as Irreversible and Selective Inhibitors of Staphylococcus aureus Sortase A

IF3.4

2020-03-2530

OA

Proline-Based Allosteric Inhibitors of Zika and Dengue Virus NS2B/NS3 Proteases

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2019-11-2669

PREAI

Cis autocatalytic cleavage of glycine-linked Zika virus NS2B-NS3 protease constructs

IF3

2019-07-0912

OAAI

Three distinct clinical presentations of the diffuse idiopathic pulmonary neuroendocrine cell hyperplasia

EUROPEAN RESPIRATORY JOURNAL

IF21

2017-12-060

PRE